Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.61
+0.75 (4.20%)
Nov 21, 2024, 1:38 PM EST - Market open
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $1.62 billion as of November 21, 2024. Its market cap has increased by 200.22% in one year.
Market Cap
1.62B
Enterprise Value
1.68B
1-Year Change
200.22%
Ranking
Category
Stock Price
$18.61
Market Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $1.62B, an increase of 3,909.18%. That is a compound annual growth rate of 36.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.39B | 106.34% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.60B |
| Neumora Therapeutics | 1.59B |
| Certara | 1.59B |
| Dynavax Technologies | 1.58B |
| Teladoc Health | 1.54B |
| Kiniksa Pharmaceuticals International, | 1.50B |
| InMode | 1.50B |
| BioCryst Pharmaceuticals | 1.49B |